• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录因子 Ikaros 在骨髓增殖性肿瘤中的缺失。

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

机构信息

Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

出版信息

Leukemia. 2010 Jul;24(7):1290-8. doi: 10.1038/leu.2010.99. Epub 2010 May 27.

DOI:10.1038/leu.2010.99
PMID:20508609
Abstract

Transformation to acute leukemia is a major complication of myeloproliferative neoplasms (MPNs), however, the genetic changes leading to transformation remain largely unknown. We screened nine patients with post-MPN leukemia for chromosomal aberrations using microarray karyotyping. Deletions on the short arm of chromosome 7 (del7p) emerged as a recurrent defect. We mapped the common deleted region to the IKZF1 gene, which encodes the transcription factor Ikaros. We further examined the frequency of IKZF1 deletions in a total of 29 post-MPN leukemia and 526 MPN patients without transformation and observed a strong association of IKZF1 deletions with post-MPN leukemia in two independent cohorts. Patients with IKZF1 loss showed complex karyotypes, and del7p was a late event in the genetic evolution of the MPN clone. IKZF1 deletions were observed in both undifferentiated and differentiated myeloid cell types, indicating that IKZF1 loss does not cause differentiation arrest but rather renders progenitors susceptible to transformation, most likely through chromosomal instability. Induced Ikzf1 haploinsufficiency in primary murine progenitors resulted in elevated Stat5 phosphorylation and increased cytokine-dependent growth, suggesting that reduced expression of IKZF1 is sufficient to perturb growth regulation. Thus, IKZF1 loss is an important step in the leukemic transformation of a subpopulation of MPN patients.

摘要

向急性白血病的转化是骨髓增殖性肿瘤(MPN)的一个主要并发症,然而,导致转化的遗传改变在很大程度上仍然未知。我们使用微阵列染色体组型分析筛选了 9 名 MPN 后白血病患者的染色体异常。7 号染色体短臂缺失(del7p)是一种反复出现的缺陷。我们将常见缺失区域定位到编码转录因子 Ikaros 的 IKZF1 基因上。我们进一步检查了总共 29 例 MPN 后白血病和 526 例无转化 MPN 患者中 IKZF1 缺失的频率,在两个独立的队列中观察到 IKZF1 缺失与 MPN 后白血病之间存在强烈关联。具有 IKZF1 缺失的患者表现出复杂的核型,并且 del7p 是 MPN 克隆遗传进化中的晚期事件。在未分化和分化的髓样细胞类型中均观察到 IKZF1 缺失,表明 IKZF1 缺失不会导致分化停滞,而是使祖细胞易发生转化,这很可能是通过染色体不稳定。在原代鼠祖细胞中诱导 Ikzf1 单倍不足会导致 Stat5 磷酸化增加和细胞因子依赖性生长增加,表明 IKZF1 表达减少足以扰乱生长调节。因此,IKZF1 缺失是 MPN 患者亚群白血病转化的重要步骤。

相似文献

1
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.转录因子 Ikaros 在骨髓增殖性肿瘤中的缺失。
Leukemia. 2010 Jul;24(7):1290-8. doi: 10.1038/leu.2010.99. Epub 2010 May 27.
2
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.BCR-ABL1阳性急性淋巴细胞白血病中IKZF1(伊卡洛斯)缺失与无病生存期短及高累积复发率相关:一项GIMEMA AL WP报告
J Clin Oncol. 2009 Nov 1;27(31):5202-7. doi: 10.1200/JCO.2008.21.6408. Epub 2009 Sep 21.
3
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.IKZF1 缺失可预测经统一治疗的儿童前体 B-ALL 的复发。
Leukemia. 2010 Jul;24(7):1258-64. doi: 10.1038/leu.2010.87. Epub 2010 May 6.
4
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.骨髓增殖性肿瘤中的新突变及其功能和临床相关性:JAK2、MPL、TET2、ASXL1、CBL、IDH 和 IKZF1。
Leukemia. 2010 Jun;24(6):1128-38. doi: 10.1038/leu.2010.69. Epub 2010 Apr 29.
5
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.BCR-ABL1 淋巴细胞白血病的特征是 Ikaros 缺失。
Nature. 2008 May 1;453(7191):110-4. doi: 10.1038/nature06866. Epub 2008 Apr 13.
6
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.骨髓增殖性肿瘤在慢性期和疾病进展过程中的基因组完整性。
Blood. 2011 Jul 7;118(1):167-76. doi: 10.1182/blood-2011-01-331678. Epub 2011 Apr 29.
7
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia.小儿急性髓系白血病中IKZF1的复发性缺失
Haematologica. 2015 Sep;100(9):1151-9. doi: 10.3324/haematol.2015.124321. Epub 2015 Jun 11.
8
Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.肿瘤抑制因子BTG1和IKZF1在小鼠白血病发展过程中协同作用,并增加B细胞前体急性淋巴细胞白血病患者的复发风险。
Haematologica. 2017 Mar;102(3):541-551. doi: 10.3324/haematol.2016.153023. Epub 2016 Dec 15.
9
Pathology consultation on myeloproliferative neoplasms.骨髓增殖性肿瘤的病理咨询。
Am J Clin Pathol. 2012 Jul;138(1):12-9. doi: 10.1309/AJCPLRIOJP55JAYT.
10
Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.鉴定出孤啡肽作为 JAK2 V617F 依赖性细胞因子产生和骨髓重构的扩增剂在骨髓增殖性肿瘤中的作用。
FASEB J. 2012 Feb;26(2):894-906. doi: 10.1096/fj.11-193078. Epub 2011 Nov 3.

引用本文的文献

1
Emerging Roles for Transcription Factors During Mitosis.转录因子在有丝分裂过程中的新作用
Cells. 2025 Feb 12;14(4):263. doi: 10.3390/cells14040263.
2
Multifaceted roles of gene, perspectives from bench to bedside.基因的多方面作用:从实验室到临床的视角
Front Oncol. 2024 Jun 24;14:1383419. doi: 10.3389/fonc.2024.1383419. eCollection 2024.
3
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.IKZF1 突变是急性髓系白血病不良风险的独立标志物。
Leukemia. 2023 Dec;37(12):2395-2403. doi: 10.1038/s41375-023-02061-1. Epub 2023 Oct 13.
4
Epigenetics in myeloproliferative neoplasms.骨髓增殖性肿瘤中的表观遗传学
Front Oncol. 2023 Jul 13;13:1206965. doi: 10.3389/fonc.2023.1206965. eCollection 2023.
5
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.血栓性骨髓增殖性肿瘤的分子遗传学:对精准肿瘤学的启示
Diagnostics (Basel). 2023 Jan 3;13(1):163. doi: 10.3390/diagnostics13010163.
6
Molecular and genomic landscapes in secondary & therapy related acute myeloid leukemia.继发性及治疗相关急性髓系白血病的分子与基因组图谱
Am J Blood Res. 2021 Oct 15;11(5):472-497. eCollection 2021.
7
Gender-related differences in the outcomes and genomic landscape of patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.性别相关差异在骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征患者的结局和基因组图谱中的体现。
Br J Haematol. 2021 Jun;193(6):1142-1150. doi: 10.1111/bjh.17534. Epub 2021 May 24.
8
Mechanistic Basis for In Vivo Therapeutic Efficacy of CK2 Inhibitor CX-4945 in Acute Myeloid Leukemia.CK2抑制剂CX-4945在急性髓系白血病体内治疗效果的机制基础
Cancers (Basel). 2021 Mar 5;13(5):1127. doi: 10.3390/cancers13051127.
9
Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.儿童和青少年血小板增多症——分类、诊断方法和临床管理。
Ann Hematol. 2021 Jul;100(7):1647-1665. doi: 10.1007/s00277-021-04485-0. Epub 2021 Mar 12.
10
Exploiting the Microhomology-Mediated End-Joining Pathway in Cancer Therapy.利用微同源介导的末端连接通路进行癌症治疗。
Cancer Res. 2020 Nov 1;80(21):4593-4600. doi: 10.1158/0008-5472.CAN-20-1672. Epub 2020 Jul 10.